Effective treatment of advanced multiple myeloma refractory to alkylating agents. It is characterised by a clonal population of bone marrow plasma cells which secrete a monoclonal. As the cancer crowds out healthy blood cells, it can cause a breakdown of bone. Multiple myeloma is the second most common type of blood cancer after leukemia. As the multiple myeloma communitys most trusted source of information, the. Approach to the treatment of newly diagnosed multiple myeloma in. Expert guidance on current and future therapeutic strategies for multiple myeloma download pdf download this 2019 treatment algorithm that includes a list of key ongoing or. Multiple myeloma is a blood cancer that develops in the bone marrow figure 1. Multiple myeloma can present with a wide constellation of symptoms including hypercalcaemia, anaemia, renal impairment andor bony pain. Myeloma is called multiple because it frequently involves multiple areas in the body.
The three discussed below are approved for treatment of multiple myeloma. Multiple myeloma is seldom cured, although treatment can relieve symptoms, induce remission, and prolong life. Oct 03, 2019 the risk of developing multiple myeloma increases with age and those of african ancestry have a higher risk of developing myeloma. In 2015, an estimated 28,850 new cases of multiple. The following is a brief annotated summary of progress in research and treatment. This is important because your bones release calcium.
Multiple myeloma mm is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. The treatment of recurrentrefractory rr multiple myeloma depends on age, comorbidities, and previous treatment. Numerous large phase iii trials have been performed in both the newly diagnosed and. Not everyone diagnosed with myeloma needs immediate treatment for example, the condition may not be causing any problems. Expert guidance on current and future therapeutic strategies for multiple myeloma download pdf download this 2019 treatment algorithm that includes a list of key ongoing or enrolling clinical trials to help select optimal treatment options for your patients with myeloma. Supportive treatments for patients with multiple myeloma. Treatment recommendations address frontline treatment of both. Multiple myeloma also causes kidney disease in some people. How is hypercalcemia treated in patients with multiple. Multiple myeloma is the secondmost prevalent blood cancer 10% after nonhodgkins lymphoma. Multiple myeloma mm, the second most common hematological malignancy in the united states and europe, is an incurable bcell malignancy which accounts for 1. The availability of new combination regimens and the enhanced safety of. Treatment guidelines for newly diagnosed multiple myeloma.
The best time to begin treatment is keenly debated. Patients not candidates for transplant are treated with vrd for. The patient handbook focuses on the questions and decisions that a newly diagnosed patient faces. Pdf multiple myeloma mm accounts for about 10% of all hematologic malignancies. Work up of plasma cell disorders involves establishing the presence of a monoclonal. Multiple myeloma symptoms, diagnosis and treatment bmj. However, your doctor will regularly monitor your condition for signs that the disease is progressing. Myeloma is a cancer of the plasma cells in the bone marrow. Firstline treatment with zoledronic acid as compared with clodronic acid in multiple myeloma mrc myeloma ix. Plasma cells are a type of white blood cell which form part of the immune system. By seeking to customize treatments based on mapping patients genomes, were also accelerating the development of the right treatment for each patient based on his or her specific characteristics.
Highdose therapy with autologous stemcell transplantation remains the treatment of choice for patients under age 70 who are otherwise in good. If paraprotein is increasing slowly, initiation of treatment can be delayed, but therapy should be initiated immediately in the presence of new myeloma related organ damage and. The risk of developing multiple myeloma increases with age and those of african ancestry have a higher risk of developing myeloma. The advent of new, more effective, and less toxic therapies has revolutionized the management of multiple myeloma in the past decade. Objective multiple myeloma can pose a diagnostic challenge and this article highlights issues in diagnosis and provides an overview of management. Proteasome inhibitors are a staple of multiple myeloma treatment and are used throughout all stages of disease. Guidelines from the mayo stratification for myeloma and riskadapted therapy.
Treatment 1 two prior therapies should include proteasome inhibitor and lenalodimide agent and have disease progression on or within 60 days of last therapy. Since 2015, four new drugs have been approved, thus providing more options. A palumbo publishes new paradigm for the treatment of. Genomic instability, a hallmark of multiple myeloma, is already present at the stage of monoclonal gammopathy of undetermined significance mgus, 1012 but it is not clear whether mgus represents. Sep 11, 2003 multiple myeloma is a malignant disease of plasma cells that is characterised by secretion of paraprotein, humoral immunodeficiency, anaemia, lytic bone lesions, and kidney dysfunction. With median age of 66 at the time of presentation, multiple myeloma is predominantly a disease of the elderly. Corticosteroids can be taken in pill form or given intravenously. Multiple myeloma treatment regimens cancer therapy advisor. Stem cell transplant for multiple myeloma supportive treatments for patients with multiple myeloma common treatment approaches depending on the stage of the cancer, whether or not you are a candidate for a stem cell transplant, and other factors, different types of treatment may be combined at the same time or used after one another. Pdf current treatment strategies for multiple myeloma. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma.
In this case there is no need for further therapy after the end of the planned cycles of treatment. Current status relapsed disease transient response to therapy survival years diagnosis survival 35 yrs survival multiple myeloma mm is a plasma cell dyscrasia characterized by terminally differentiated plasma cells, infiltration of the bone marrow by plasma cells, and the presence of a monoclonal immunoglobulin or immunoglobulin fragment in the serum andor urine. Extramedullary intracranial localization of multiple myeloma and treatment with novel agents. This means additional treatment is needed when the cancer comes. While multiple myeloma is an incurable disease, several treatment options are available.
After treatment, i got involved in patient advocacy and started a foundation to support myeloma patients and research. Abstract multiple myeloma accounts for approximately 10% of hematologic malignancies. Exposure to radiation, organic chemicals such as benzene, herbicides, and insecticides may play a role. This patient also had a strange bone disease that we now call multiple myeloma. Methods asco and cancer care ontario convened an expert panel. Despite unprecedented advances in the treatment of multiple myeloma mm, almost all patients develop a disease that is resistant to the five most commonly used and active antimm. Definitions smoldering asymptomatic myeloma both criteria must be met. Normal plasma cells produce different types of antibodies immunoglobulins to help fight infection. Multiple myeloma affects slightly more men than women. Regarding the fundamental biology of myeloma, the presence of somatic hypermutations of immunoglobulin variable region genes is consistent with an immortalizing event during plasma cell generation in germinal centers of lymph nodes. The treatment of multiple myeloma mm continues to evolve with the approval of numerous agents over the past decade. Multiple myeloma mm, also known as plasma cell myeloma and simple myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. The journey to be actively involved in helping others was my emotional. Learn about multiple myeloma symptoms, diagnosis, risk factors, and treatment.
Background multiple myeloma is characterised by the proliferation of malignant plasma cells within the bone marrow, which produce an abnormal monoclonal paraprotein and evidence of end organ damage. Multiple myeloma treatment options treatment for multiple. If you have multiple myeloma but arent experiencing any symptoms also known as smoldering multiple myeloma, you may not need treatment. Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell leukemia. Background multiple myeloma is characterised by the proliferation of malignant plasma cells within the bone marrow, which produce an abnormal monoclonal paraprotein and evidence of end organ. Multiple myeloma can also be treated using drugs, which can be given by mouth or directly into the bloodstream. Advances in treatment have led to the incorporation of these newer therapies. Aug 16, 2018 the revised international myeloma working group criteria for the diagnosis of multiple myeloma and related disorders are shown on table 1. Multiple myeloma accounts for approximately 10% of hematologic malignancies. Multiple myeloma mm is a plasma cell dyscrasia characterized by terminally differentiated plasma cells, infiltration of the bone marrow by plasma cells, and the presence of a monoclonal immunoglobulin or. Consider clinical trials as treatment options for eligible patients. Multiple myeloma is characterized by the uncontrolled proliferation of monoclonal plasma cells in the bone marrow, leading to production of. The goals of therapy for young patients with multiple myeloma is to achieve the. We hope that the information will be helpful to both healthcare professionals and patients.
Multiple myeloma accounts for 1% of all cancers and approximately 10% of all haematological malignancies. Jul 11, 2016 the treatment of recurrentrefractory rr multiple myeloma depends on age, comorbidities, and previous treatment. Serum monoclonal protein igg or iga greater than or equal to 30 gl or urinary monoclonal protein greater. First described in 1848, mm is characterized by a proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein m protein. The standard treatment with intermittent courses of melphalan and. We see a world where every person has precisely what he or she needs to prevent or defeat multiple myeloma. Selinexor for the treatment of multiple myeloma request pdf. Purpose to provide evidencebased recommendations on the treatment of multiple myeloma to practicing physicians and others. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma.
Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma. Treatment for multiple myeloma can often help to control symptoms and improve quality of life. Maintenance therapy with thalidomide improves survival in patients with multiple myeloma. Questions to ask your doctor about multiple myeloma. The phases of multiple myeloma treatment included initial therapy, stem cell transplantation if patient is eligible and maintenance therapy, in addition to treating relapse cases. Although the median survival of patients with multiple myeloma has improved from seven months to five years with treatment, the disease remains largely incurable. Since 2015, four new drugs have been approved, thus providing more options and adding to the complexity of treatment options table 1. Jan 25, 2020 the phases of multiple myeloma treatment included initial therapy, stem cell transplantation if patient is eligible and maintenance therapy, in addition to treating relapse cases. Despite the availability of new treatments, most patients with. The diagnosis and treatment of multiple myeloma ncbi.
Multiple myeloma blood american society of hematology. The nccn recommends cancer patient participation in clinical trials as the gold standard for treatment. Multiple myeloma is a type of cancer that affects plasma cells. Side effects of thalidomide can include drowsiness, fatigue, severe constipation, and painful nerve damage neuropathy6. Multiple myeloma diagnosis and treatment mayo clinic. Multiple myeloma, the most common bone malignancy, is occurring with increasing frequency in older persons. Myeloma is called multiple because it frequently involves multiple areas in the. Earlier melphalan based combination therapy was prevalent. A combination of these symptoms, particularly if unexpected or unexplained, should prompt diagnostic evaluation for myeloma. In combination with other drugs, corticosteroids are often used throughout the course of multiple myeloma treatment.
Treatment options for tripleclass refractory multiple myeloma. Please use one of the following formats to cite this article in your essay, paper or report. These systemic therapies can reach cancer cells anywhere in the body. The multiple myeloma research foundation mmrf is helping accelerate the development of the next multiple myeloma treatments. Treatment of multiple myeloma blood american society. Other treatment options for multiple myeloma corticosteroids, such as prednisone and dexamethasone, control inflammation in the body and can also fight myeloma cells. These updated esmo clinical practice guidelines cover the diagnosis and pathologymolecular biology, staging and risk assessment and response evaluation of multiple myeloma. Feb 27, 2019 please use one of the following formats to cite this article in your essay, paper or report.
Treatment of multiple myeloma blood american society of. Initial treatment of patients with multiple myeloma who are transplant ineligible should include at minimum. Patients may present with bone pain or with symptoms that are often nonspecific, such as nausea. Update on the initial therapy of multiple myeloma ariez publishing. If you develop signs and symptoms or your multiple. Multiple myeloma mm, also known as symptomatic plasma cell myeloma, is a plasma cell malignancy. The treatment of multiple myeloma has changed signi. Racial disparities in incidence and outcome in multiple myeloma. This means additional treatment is needed when the cancer comes back a relapse. Later, it became available again as a treatment for multiple myeloma. The imfs patient handbook is designed to help you to understand multiple myeloma which we refer to simply as myeloma.
571 65 159 299 826 59 1145 1005 23 675 441 44 1522 329 513 952 256 1311 96 896 1407 1449 448 358 1192 1076 1141 674 829 908 607 776 621 722